A detailed history of Eam Investors, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 95,019 shares of ETON stock, worth $1.41 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
95,019
Previous 128,276 25.93%
Holding current value
$1.41 Million
Previous $769,000 62.42%
% of portfolio
0.2%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$5.9 - $13.15 $196,216 - $437,329
-33,257 Reduced 25.93%
95,019 $1.25 Million
Q3 2024

Nov 13, 2024

BUY
$3.28 - $6.0 $420,745 - $769,656
128,276 New
128,276 $769,000
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.63 $654,388 - $1.44 Million
256,623 New
256,623 $1.07 Million

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $375M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.